-+ 0.00%
-+ 0.00%
-+ 0.00%

Shisi Pharmaceutical Group (02005) obtained drug production registration approval for sodium glycerophosphate injection (10ml:2.16g)

Zhitongcaijing·12/29/2025 00:25:02
Listen to the news

Zhitong Finance App News, Shisi Pharmaceutical Group (02005) announced that the Group has obtained approval from the China National Drug Administration for drug production registration for sodium glycerophosphate injection (10ml: 2.16g). It is a Class 4 chemical drug. It is considered to have passed the consistency evaluation, and is the third domestic company to be approved. Sodium glycerophosphate injection is a nutritional medicine, mainly used as a phosphorus supplement for parenteral nutrition in adults and for patients with phosphorus deficiency.